Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug–Associated Thrombosis Among Patients With Multiple MyelomaAng Li, Kristen M. Sanfilippo|Journal of the National Comprehensive Cancer Network|2019Cited by 146
Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC TrialJunyang Lu, Ang Li, Jiadi Xing et al.|Journal of Clinical Oncology|2024Cited by 43
Multifunctional silica nanocomposites prime tumoricidal immunity for efficient cancer immunotherapyLinnan Yang, Ang Li|Journal of Nanobiotechnology|2021Cited by 33
The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19Ang Li, Rachel Rosovsky, Shuchi Gulati et al.|Journal of Thrombosis and Haemostasis|2021Cited by 30
Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) RegistryAng Li, Rachel Rosovsky, Nicole M. Kuderer et al.|Blood|2020Cited by 8